Showing results (1-10 of 716) with videos related to

Sort By:
Pageof 72
Best Practice & Research. Clinical Endocrinology & Metabolism|September 10, 2003
Methods for clinical assessment of insulin sensitivity and beta-cell functionGiovanni Pacini, Andrea Mari
Current Opinion in Clinical Nutrition and Metabolic Care|August 5, 2005
Assessment of insulin secretion in relation to insulin resistanceAndrea Mari, Bo Ahrén, Giovanni Pacini
Diabetes, Obesity & Metabolism|December 3, 2019
Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetesWathik Alsalim, Olga Göransson, Andrea Tura, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2014
Incretin and islet hormone responses to meals of increasing size in healthy subjectsWathik Alsalim, Bilal Omar, Giovanni Pacini, et al.
Plos One|November 28, 2012
Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parametersAndrea Tura, Angela Grassi, Yvonne Winhofer, et al.
Metabolism: Clinical and Experimental|September 28, 2011
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic modelsAndrea Tura, Giovanni Pacini, Alexandra Kautzky-Willer, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 15, 2006
The hyperbolic equilibrium between insulin sensitivity and secretionGiovanni Pacini
Diabetes, Obesity & Metabolism|December 12, 2017
Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjectsWathik Alsalim, Olga Göransson, Richard D Carr, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Incretin hormone and insulin responses to oral versus intravenous lipid administration in humansOla Lindgren, Richard D Carr, Carolyn F Deacon, et al.
Endocrinology, Diabetes & Metabolism|October 14, 2022
Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivityPierre Theurey, Carole Thang, Valdis Pirags, et al.
Pageof 72